Saneca investing €3.5m into small-scale API capabilities
Saneca Pharma says the expanded capabilities will feed demand for small-scale API batches to support clients’ R&D projects.
Archives for September 14, 2016
Bayer committed to pharma R&D and CapEx despite planned Monsanto buy
Bayer has said it will not cut drug R&D or manufacturing investment as a result of its planned acquisition of Monsanto.
PSI selects goBalto's site ID cloud-based software to speed up trials
PSI has selected goBalto’s cloud-based Select module management system to help manage a multi-country Phase II clinical trial.
Teva months from restarting production at Hungary plant banned by US FDA
Teva expects to restart drug manufacturing at the Hungarian plant under US import alert in the next few months.
Fragile X drug developer Fulcrum to use Horizon's CRISPR to find gene targets
Fulcrum Therapeutics will use a CRISPR gene editing-based platform to identify genetic targets under a deal with Horizon Discovery Group.